Status:
COMPLETED
Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting
Lead Sponsor:
Fondazione Poliambulanza Istituto Ospedaliero
Conditions:
Colonic Neoplasms
Colonic Adenocarcinoma
Eligibility:
All Genders
50-69 years
Phase:
NA
Brief Summary
Even if colonoscopy is considered the reference standard for the detection of colonic neoplasia, polyps are still missed. The risk of early post-colonoscopy cancer appeared to be independently predict...
Detailed Description
Even if colonoscopy is considered the reference standard for the detection of colonic neoplasia, polyps are still missed. In large administrative cohort or case-control studies, the risk of early post...
Eligibility Criteria
Inclusion
- Patients aged 50 to 69 undergoing colonoscopy examination following a positive fecal immunochemical test (FIT) performed in the context of a regional mass-screening program.
Exclusion
- Patients unwilling or unable to give informed consent.
- Patients reporting use of anti-platelet agents or anticoagulants precluding removal of polyps.
Key Trial Info
Start Date :
May 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04441580
Start Date
May 4 2020
End Date
December 31 2023
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Poliambulanza Istituto Ospedaliero
Brescia, Italy